IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Karyopharm Therapeutics Inc (KPTIEUR)

CUSIP: 48576U106 | X1 | 544 institutional holders

Quarters

Q2 2026Q1 2026Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Birchview Capital, LP42,952
0.2% of portfolio›$419.6K
StyleTurnoverLocationFiled
Birchview Capital, LP
42,952$419.6K0.2%CoreHighBurlington, VT2026-08-14